Quintiles News

Please select a press release from the list below, or filter and sort to find a specific press release.

logos_Expression Analysis-Quintiles
Latest Press Release

Expression Analysis Announces 2014 Grant Program

RESEARCH TRIANGLE PARK, NC – August 19, 2014 – Expression Analysis (EA), a Quintiles company, today announced that it is co-sponsoring a grant program that provides scientists with leading-edge products and services to advance genomics research. In the sixth year of the grant program, EA and co-sponsor, Illumina, will award two fully funded oncology research grants. Each grant will enable winners to investigate genomic data locked within Formalin-Fixed, Paraffin Embedded... Learn More
Published Date: 2014 2013 2012 2011 2010 2009
Press Release Aug 19, 2014
RESEARCH TRIANGLE PARK, NC – August 19, 2014 – Expression Analysis (EA), a Quintiles company, today announced that it is co-sponsoring a grant program that provides scientists with leading-edge products and services to advance genomics research. In the sixth year of the grant program, EA and co-sponsor, Illumina, will award two fully funded oncology research grants. Each grant will enable winners to investigate genomic data locked within Formalin-Fixed, Paraffin Embedded (FFPE) tumor samples - focusing on a largely untapped data pool in an effort to enhance researchers’ understanding of cancer biology. “Our grant program offers motivation, encouragement and resources to researchers who share our commitment to identify genetic factors that influence health and disease,” said Steve McPhail,...
Read More
Press Release Aug 18, 2014
HOUSTON – August 18, 2014 – For the fifth consecutive year, Modern Healthcare has named Encore, A Quintiles Company (formerly Encore Health Resources), one of the Best Places to Work in Healthcare. Encore, a leader in the health-information analytics and technology consulting services focused on healthcare providers, has been recognized on this coveted list every year since the company began operations in 2009. The Best Places to Work in Healthcare award is based on employee survey results and recognizes outstanding employers in the healthcare industry on a national level. “I am once again honored to receive Modern Healthcare’s Best Places to Work in Healthcare award,” said Dana Sellers, CEO, Encore, A Quintiles Company. “The award is confirmation that the combination of open...
Read More
Press Release Jul 31, 2014
Research Triangle Park, NC, July 31, 2014 – Quintiles Transnational Holdings Inc. (“Quintiles” or the “Company”) (NYSE: Q) today reported its financial results for the second quarter ended June 30, 2014. 9.7% consolidated service revenue growth - Integrated Healthcare Services segment grew service revenues by 15.6% compared to the second quarter 2013 21.2% net new business growth compared to the second quarter 2013 representing a book-to-bill ratio of 1.19 Second quarter diluted adjusted EPS increased 30% to $0.65 per share compared to the second quarter of 2013 Second quarter GAAP reported diluted EPS increased 113% to $0.64 per share compared to the second quarter of 2013 Increased full year 2014 service revenue guidance to $4.20 billion - $4.24 billion and...
Read More
Press Release Jul 21, 2014
READING, UK – July 21, 2014 – Quintiles has been recognized for its commitment to employee health and wellness, taking the 2014 “Britain’s Healthiest Workplace” award at a ceremony addressed by Dame Carol Black and Lord Sebastian Coe. Britain’s Healthiest Company aims to celebrate organizations that have an outstanding approach to their employees’ health and wellbeing and is the UK’s largest survey into employee health. In 2014 more than 80 companies were surveyed on criteria including facilities, culture and work environment. Quintiles UK Head Lindy Jones said, “Our work on developing and commercializing medicines means that every day we are focused on improving the lives of people in the UK and beyond. A proactive approach to health and wellbeing is integral to living a full and healthy...
Read More
Press Release Jun 23, 2014
RESEARCH TRIANGLE PARK, N.C. – June 23, 2014 – Quintiles, the world’s largest biopharmaceutical services provider and a Fortune 500 company, has been named one of IDG Computerworld's 100 Best Places to Work in IT 2014, the sixth time it has received this employer distinction over the past seven years. Computerworld has ranked the top 100 work environments for technology professionals at U.S. companies or U.S. staff of international companies each year since 1994. The list is compiled each year based on company offerings in categories such as benefits, career development, training and retention. In addition, Computerworld conducts extensive surveys of IT workers with their responses factoring heavily in determining the rankings. “We are delighted to be named for the sixth time as one of...
Read More
Press Release Jun 19, 2014
RESEARCH TRIANGLE PARK, N.C. and BINGHAMTON, N.Y. – June 19, 2014 – Quintiles and Modern Marketing Concepts (MMC, Inc.) today announced the launch of a new marketing analytics platform that enables Quintiles to optimize sales and marketing efforts on behalf of its U.S. commercialization customers. Through this collaboration, Quintiles and MMC combine proprietary channel preference data with the innovative Next Action Marketing platform to create optimized physician communication strategies that align with their preferences and behaviors. “As physicians and the healthcare industry evolve, we need real-time data analytics to maximize our outreach efforts and ensure we are utilizing the most effective ways to reach physicians,” said Daryl Gaugler, senior vice president, Commercial Solutions...
Read More
Press Release Jun 10, 2014
RESEARCH TRIANGLE PARK, N.C. and ALEXANDRIA, Va. – June 10, 2014 – Quintiles and the American Physical Therapy Association (APTA) today announced a new strategic collaboration to develop and implement the Physical Therapy Outcomes Registry—which will be the largest and most comprehensive physical therapy electronic repository to date. “Patient registries are an increasingly vital component of real-world, comprehensive evidence development for identifying the causes of disease and, in this case, injuries, and designing effective treatments,” said Cynthia Verst, president of Real-World & Late Phase Research at Quintiles. “Working together with APTA and leveraging our expertise in designing and implementing registries, our goal is to build a new registry that will provide clinicians and...
Read More
Press Release Jun 09, 2014
RESEARCH TRIANGLE PARK, NC – June 9, 2014 – For the second year in a row, Quintiles has been named the CRO industry leader in Phase I services according to respondents in Industry Standard Research’s (ISR) report, CRO Quality Benchmarking Phase I Service Providers (2014). In this year’s survey, Quintiles was recognized as the “overwhelming leader” when survey respondents were asked to identify CROs they consider leaders in the Phase I space. This announcement follows Quintiles’ recognition, also for the second year in a row, as the industry leader that best differentiates itself on service quality for Phase II/III research in an earlier ISR report released in April. In this new report, Quintiles was mentioned by 60% of the 113 decision-makers who were surveyed around the globe as the...
Read More
Press Release Jun 06, 2014
RESEARCH TRIANGLE PARK, N.C. – June 6, 2014 – Quintiles, the world’s largest biopharmaceutical services provider, has been named to the 2014 CIO 100. Each year, CIO magazine identifies and honors 100 organizations that have distinguished themselves by creating business value through the effective and innovative use of IT. Quintiles was named to the CIO 100 because of its transformational Quintiles Infosario® Safety solution, a drug safety technology platform which is fully integrated with relevant regulatory agencies and future-proofed through a community development model. “We are honored to be included in the CIO 100 for our work in helping to solve industry and customer challenges,” said Quintiles CIO Richard Thomas. “Introduced in 2011, our award-winning Infosario solutions combine...
Read More
Press Release Jun 05, 2014
RESEARCH TRIANGLE PARK, N.C. – June 5, 2014 – Quintiles CFO Kevin Gordon will present at the 2014 Wells Fargo Healthcare Conference on Tuesday, June 17, 2014 in Boston’s InterContinental Hotel. The Quintiles presentation will begin at 1:10 p.m. (EDT). Investors may access a live audio webcast of the presentation on the Quintiles investor relations website at www.quintiles.com/investors. An archived audio version of the presentation will be available later that day. About Quintiles Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 29,000 employees conducting business in approximately 100 countries. We helped develop or commercialize all of 2013’s top-100 best-selling drugs on the market....
Read More
Press Release Jun 02, 2014
RESEARCH TRIANGLE PARK, N.C. – June 2, 2014 – Quintiles, the world’s largest biopharmaceutical services provider, has been named to the Fortune 500 list of largest U.S. companies ranked by revenue. “Being named to the Fortune 500 is a significant milestone in Quintiles’ history,” said CEO Tom Pike. “We operated as a private company for a full decade before returning to the public markets via IPO in 2013. Our inclusion in the Fortune 500 is another indicator that Quintiles is one of the most important companies headquartered in the United States, conducting business in 100 countries. “Quintiles’ management and our 29,000-plus employees around the world take great pride in what this accomplishment says about the impact and forward thinking of this company,” Pike continued. “We come to work...
Read More
Press Release May 19, 2014
RESEARCH TRIANGLE PARK, N.C. – May 19, 2014 – Quintiles CFO Kevin Gordon will present at the Jefferies 2014 Global Healthcare Conference on Tuesday, June 3, 2014 in New York City at the Grand Hyatt New York. The Quintiles presentation will begin at 1:30 p.m. (EDT). Investors may access a live audio webcast of the presentation on the Quintiles’ investor relations website at www.quintiles.com/investors. An archived audio version of the presentation will be available later that day. About Quintiles Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 29,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on...
Read More
Press Release May 12, 2014
RESEARCH TRIANGLE PARK, N.C. – May 12, 2014 – As part of its continued efforts to strengthen and expand its service capabilities across the healthcare continuum, Quintiles today announced that it has signed an agreement to acquire Encore Health Resources (Encore). Encore is a leader in the health-information analytics and technology services industry focused on healthcare providers. Through its consulting services and solutions, Encore assists customers with a wide range of strategy, advisory, implementation, process-redesign, optimization, analytics and performance-improvement initiatives. Founded in 2009, Encore has more than 300 employees located throughout North America, including approximately 250 consultants. Its primary business is focused on implementation and advisory...
Read More
Press Release May 06, 2014
RESEARCH TRIANGLE PARK, N.C. – May 6, 2014 – Quintiles CFO Kevin Gordon will present at the Bank of America Merrill Lynch 2014 Health Care Conference on Thursday, May 15, 2014 in Las Vegas at the Encore Wynn. The Quintiles presentation will begin at 10:40 a.m. (PDT). Investors may access a live audio webcast of the presentation on the Quintiles’ Investor Relations website at www.quintiles.com/investors. An archived audio version of the presentation will be available later that day. About Quintiles Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 29,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs...
Read More
Press Release May 02, 2014
RESEARCH TRIANGLE PARK, NC – May 2, 2014 – Quintiles today announced that the U.S. Agency for Healthcare Research and Quality (AHRQ) has published the third edition of “Registries for Evaluating Patient Outcomes: A User’s Guide.” Quintiles’ Real-World & Late Phase Research division, a leading provider of patient registries, studies and technologies for evaluating patient outcomes, has led this effort to create the patient registries reference since 2005. This publication provides a comprehensive guide to the design, operation, analysis and evaluation of patient registries. The handbook is a widely used reference in the United States, Europe and Asia, and previous editions have been cited extensively in the peer-reviewed literature as the standard for designing, conducting and evaluating...
Read More
Press Release May 01, 2014
Research Triangle Park, NC – May 1, 2014 – Quintiles Transnational Holdings Inc. (“Quintiles” or the “Company”) (NYSE: Q) today reported its financial results for the first quarter ended March 31, 2014.Over $1.0 billion of service revenues representing 8.4% growth; Integrated Healthcare Services segment grew service revenues by 6.0% in the quarterNet new business wins of $1.27 billion representing a book-to-bill ratio of 1.27First quarter diluted adjusted EPS increased 39% to $0.68 and adjusted net income increased 58% to $90.9 million compared to the first quarter of 2013First quarter GAAP reported diluted EPS increased 66% to $0.68 and GAAP reported net income increased 87% to $90.2 million compared to the first quarter of 2013Increased full year 2014 service revenue guidance to $4.13...
Read More
Press Release Apr 24, 2014
RESEARCH TRIANGLE PARK, N.C. – April 24, 2014 – Quintiles, the world’s largest provider of biopharmaceutical development and commercial outsourcing services, and Biogen Idec (NASDAQ: BIIB) have entered into a five-year strategic clinical development agreement. The multi-year collaboration is designed to leverage the expertise and experience from both organizations to optimize Biogen Idec’s clinical development processes. The collaboration is structured to increase clinical trial efficiency, with a focus on transparency, quality, innovation and operational excellence. Under the agreement, a dedicated team from Quintiles will work with Biogen Idec on the design, planning and execution of Biogen Idec’s phase II-IV studies and select phase I studies. In addition, Biogen Idec will leverage...
Read More
Press Release Apr 17, 2014
RESEARCH TRIANGLE PARK, NC – April 17, 2014 – For the second year in a row, Quintiles has been named the industry leader that best differentiates itself on service quality for Phase II/III research in Industry Standard Research’s (ISR) 2014 CRO Quality Benchmarking Phase II/III Service Providers Report. According to the 148 pharmaceutical and biotechnology decision makers surveyed by ISR in this year’s report, Quintiles is the preferred provider for Phase II/III research among small, mid-size and large biopharmaceutical companies. “At Quintiles, we are focused on leading our customers through an increasingly complex and ever-changing drug development landscape,” said Paula Brown Stafford, president of Clinical Development at Quintiles. “We are delighted once again to be recognized as...
Read More
Press Release Apr 09, 2014
RESEARCH TRIANGLE PARK, N.C. – April 9, 2014 – Quintiles Transnational Holdings Inc. (NYSE: Q) will release its financial results for the first quarter of 2014 prior to its quarterly earnings call on Thursday, May 1, 2014, at 8:00 a.m. EDT. The conference call will be accessible, live via webcast, on the Investor Relations section of the Quintiles website at www.quintiles.com/investors. To participate via telephone, please dial +1 (855) 484-7367 in the United States or +1 (631) 259-7541 outside the United States, approximately 15 minutes before the scheduled start of the call. An archived edition of the conference call will be available online at www.quintiles.com/investors after 1:00 p.m. EDT on Thursday, May 1st. About Quintiles Quintiles (NYSE: Q) is the world’s largest provider of...
Read More
Press Release Mar 27, 2014
RESEARCH TRIANGLE PARK, NC – March 27, 2014 – Quintiles today announced that Stella Blackburn, M.B. B.S., has been appointed as the vice president and global head of Risk Management for its Real-World & Late Phase Research group. In this role, Dr. Blackburn will be responsible for leading the group’s risk management efforts in North America, EU and Asia-Pacific. Dr. Blackburn also will develop multidisciplinary benefit risk management services, review and assist customers with interpretation of pharmacovigilance legislation, and ensure compliance with regulations and best practices in the conduct of pharmacovigilance and risk management activities for the company’s real-world and late phase research efforts. With more than two decades of experience in the pharmacovigilance and...
Read More